Actively Recruiting
Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients
Led by Tanta University · Updated on 2024-09-19
70
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to compare patient satisfaction and intubating conditions during fiberoptic intubation performed under two different methods for patients with difficult airways. The study focuses on adults ages 18 to 50 who have anticipated difficult intubation due to airway anatomy or pathology. Awake fiberoptic intubation (AFOI) usually requires a calm and cooperative patient with reduced airway reflexes, and sedative or anxiolytic agents are used to help achieve comfort without affecting breathing. Participants will be randomly assigned to one of two groups. One group will have fiberoptic intubation under sevoflurane sedation, while the other will receive bilateral Superior Laryngeal Nerve blocks and Recurrent Laryngeal nerve blocks with 2% Xylocaine before intubation. Both approaches are intended to facilitate the procedure in difficult airway cases, and the trial compares these methods for patient comfort and procedural conditions. During the study, several measures will be taken including patient satisfaction immediately after intubation, intubation time, heart rate, mean arterial pressure, and patient tolerance to endoscopy and intubation. These assessments will happen during and shortly after the procedure to evaluate the experience and physiological responses. The entire process involves careful monitoring to assess the safety and comfort of both approaches in this patient group.
CONDITIONS
Brief Title
Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age from 18 to 50 years
- Both sexes
- American Society of Anesthesiology (ASA) physical status I-II
- Patients with difficult airway (Mallampati grade 3 and 4 with mouth opening less than 5 cm)
You will not qualify if you...
- Patient refusal
- Patients with bleeding disorders and nasal mass
- Allergy or intolerance to one of the study medications
- Patients with uncontrolled systemic diseases
- Patients with gastro-esophageal reflux
- History of nasopharyngeal surgery or drug abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of intubation
Participants receive fiberoptic intubation under sedation or nerve block as part of the study procedure.
1 visit (in-person)
Duration - Up to 5 minutes after intubation
Participants are monitored immediately and within minutes after intubation for satisfaction and vital signs.
1 follow-up visit (in-person)
Trial Site Locations
Total: 1 location
1
Tanta University
Tanta, El-Gharbia, Egypt, 31527
Actively Recruiting
Research Team
M
Marwa A Abogabal, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here